Scott Askin
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Biomedical Ethics and Regulation, Ethics in Clinical Research, Health Systems, Economic Evaluations, Quality of Life, Electronic Health Records Systems, Biosimilars and Bioanalytical Methods
Most-Cited Works
- → Artificial Intelligence Applied to clinical trials: opportunities and challenges(2023)244 cited
- → Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective(2022)110 cited
- → Evolving regulatory perspectives on digital health technologies for medicinal product development(2023)50 cited
- → Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting(2016)45 cited
- → Digital technologies for medicines: shaping a framework for success(2020)42 cited
- → Regulatory Interactions and Learnings— RADIAL the Trials@Home Proof‐of‐Concept Trial on Decentralization(2025)
- → Additional file 1: of Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting(2016)
- → Recommendation Paper on Advancing the Use of Decentralised Elements in Clinical Trials(2025)
- Medical experience in Thailand.(1962)